Stock data
Pliant Therapeutics, Inc. (PLRX)
Pliant Therapeutics, Inc. (PLRX) reported revenue of US$0.00M and net income of -US$149.34M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$156.37M | -US$149.34M | — |
| 2024 | US$0.00M | — | -US$228.37M | -US$210.30M | — |
| 2023 | US$1.58M | — | -US$184.15M | -US$161.34M | — |
| 2022 | US$9.69M | — | -US$127.20M | -US$123.32M | — |
| 2021 | US$7.57M | — | -US$97.53M | -US$97.26M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$22.37M | — |
| 2026-03-31 | — | -US$20.04M | — |
| 2025-12-31 | — | -US$23.58M | — |
| 2025-09-30 | — | -US$26.30M | — |
| 2025-06-30 | — | -US$43.30M | — |
| 2025-03-31 | — | -US$56.17M | — |
| 2024-12-31 | US$0.00M | -US$49.73M | — |
| 2024-09-30 | US$0.00M | -US$57.76M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.